News

At the FDA's request, delandistrogene moxeparvovec (Elevidys), the only approved gene therapy for Duchenne muscular dystrophy ...
A father of two sons diagnosed with muscular dystrophy is organizing a cornhole tournament this weekend to raise money for ...
Norwegian documentary, The Remarkable Life of Ibelin, directed by Benjamin Ree, chronicles the life of Mats Steen, who had ...
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular ...
AI-based digital twin modeling predicts patient-specific decline, addressing key trial design and biomarker challenges in FSHD ...
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular ...
Capricor Therapeutics's dip caused by the CRL is a buying opportunity considering the readout of HOPE-3 within 2-3 months.
In total, 11 abstracts on givinostat were accepted for presentation at the Congress, including two for an oral presentation ...